866-997-4948(US-Canada Toll Free)

Global Ophthalmic Therapeutics/Drug Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Mar 2019

Category :

Pharmaceutical

No. of Pages : 115 Pages

The global Ophthalmic Therapeutics/Drug market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Ophthalmic Therapeutics/Drug market based on company, product type, end user and key regions.

This report studies the global market size of Ophthalmic Therapeutics/Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Ophthalmic Therapeutics/Drug in these regions.
This research report categorizes the global Ophthalmic Therapeutics/Drug market by top players/brands, region, type and end user. This report also studies the global Ophthalmic Therapeutics/Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Alcon
Johnson and Johnson Vision Care, Inc.
Bausch & Lomb Incorporated
Novartis AG
Merck Sharp & Dohme Corp.
Regeneron Pharmaceuticals Inc.
Allergan
Pfizer Inc.
Valeant
Bayer AG
Santen Pharmaceuticals Co. Ltd
Genentech, Inc.

Market size by Product
Anti-allergy
Anti-VEGF Agents
Anti-inflammatory
Anti-glaucoma
Others
Market size by End User
Dry Eye
Allergies
Glaucoma
Infection
Retinal Disorders
Uveitis
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Ophthalmic Therapeutics/Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Ophthalmic Therapeutics/Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Ophthalmic Therapeutics/Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Ophthalmic Therapeutics/Drug submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Ophthalmic Therapeutics/Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Ophthalmic Therapeutics/Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Ophthalmic Therapeutics/Drug Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Ophthalmic Therapeutics/Drug Market Size Growth Rate by Product
1.4.2 Anti-allergy
1.4.3 Anti-VEGF Agents
1.4.4 Anti-inflammatory
1.4.5 Anti-glaucoma
1.4.6 Others
1.5 Market by End User
1.5.1 Global Ophthalmic Therapeutics/Drug Market Size Growth Rate by End User
1.5.2 Dry Eye
1.5.3 Allergies
1.5.4 Glaucoma
1.5.5 Infection
1.5.6 Retinal Disorders
1.5.7 Uveitis
1.5.8 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Ophthalmic Therapeutics/Drug Market Size
2.1.1 Global Ophthalmic Therapeutics/Drug Revenue 2014-2025
2.1.2 Global Ophthalmic Therapeutics/Drug Sales 2014-2025
2.2 Ophthalmic Therapeutics/Drug Growth Rate by Regions
2.2.1 Global Ophthalmic Therapeutics/Drug Sales by Regions
2.2.2 Global Ophthalmic Therapeutics/Drug Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Ophthalmic Therapeutics/Drug Sales by Manufacturers
3.1.1 Ophthalmic Therapeutics/Drug Sales by Manufacturers
3.1.2 Ophthalmic Therapeutics/Drug Sales Market Share by Manufacturers
3.1.3 Global Ophthalmic Therapeutics/Drug Market Concentration Ratio (CR5 and HHI)
3.2 Ophthalmic Therapeutics/Drug Revenue by Manufacturers
3.2.1 Ophthalmic Therapeutics/Drug Revenue by Manufacturers (2014-2019)
3.2.2 Ophthalmic Therapeutics/Drug Revenue Share by Manufacturers (2014-2019)
3.3 Ophthalmic Therapeutics/Drug Price by Manufacturers
3.4 Ophthalmic Therapeutics/Drug Manufacturing Base Distribution, Product Types
3.4.1 Ophthalmic Therapeutics/Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Ophthalmic Therapeutics/Drug Product Type
3.4.3 Date of International Manufacturers Enter into Ophthalmic Therapeutics/Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Ophthalmic Therapeutics/Drug Sales by Product
4.2 Global Ophthalmic Therapeutics/Drug Revenue by Product
4.3 Ophthalmic Therapeutics/Drug Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Ophthalmic Therapeutics/Drug Breakdown Data by End User

6 North America
6.1 North America Ophthalmic Therapeutics/Drug by Countries
6.1.1 North America Ophthalmic Therapeutics/Drug Sales by Countries
6.1.2 North America Ophthalmic Therapeutics/Drug Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Ophthalmic Therapeutics/Drug by Product
6.3 North America Ophthalmic Therapeutics/Drug by End User

7 Europe
7.1 Europe Ophthalmic Therapeutics/Drug by Countries
7.1.1 Europe Ophthalmic Therapeutics/Drug Sales by Countries
7.1.2 Europe Ophthalmic Therapeutics/Drug Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Ophthalmic Therapeutics/Drug by Product
7.3 Europe Ophthalmic Therapeutics/Drug by End User

8 Asia Pacific
8.1 Asia Pacific Ophthalmic Therapeutics/Drug by Countries
8.1.1 Asia Pacific Ophthalmic Therapeutics/Drug Sales by Countries
8.1.2 Asia Pacific Ophthalmic Therapeutics/Drug Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Ophthalmic Therapeutics/Drug by Product
8.3 Asia Pacific Ophthalmic Therapeutics/Drug by End User

9 Central & South America
9.1 Central & South America Ophthalmic Therapeutics/Drug by Countries
9.1.1 Central & South America Ophthalmic Therapeutics/Drug Sales by Countries
9.1.2 Central & South America Ophthalmic Therapeutics/Drug Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Ophthalmic Therapeutics/Drug by Product
9.3 Central & South America Ophthalmic Therapeutics/Drug by End User

10 Middle East and Africa
10.1 Middle East and Africa Ophthalmic Therapeutics/Drug by Countries
10.1.1 Middle East and Africa Ophthalmic Therapeutics/Drug Sales by Countries
10.1.2 Middle East and Africa Ophthalmic Therapeutics/Drug Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Ophthalmic Therapeutics/Drug by Product
10.3 Middle East and Africa Ophthalmic Therapeutics/Drug by End User

11 Company Profiles
11.1 Alcon
11.1.1 Alcon Company Details
11.1.2 Company Business Overview
11.1.3 Alcon Ophthalmic Therapeutics/Drug Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Alcon Ophthalmic Therapeutics/Drug Products Offered
11.1.5 Alcon Recent Development
11.2 Johnson and Johnson Vision Care, Inc.
11.2.1 Johnson and Johnson Vision Care, Inc. Company Details
11.2.2 Company Business Overview
11.2.3 Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Products Offered
11.2.5 Johnson and Johnson Vision Care, Inc. Recent Development
11.3 Bausch & Lomb Incorporated
11.3.1 Bausch & Lomb Incorporated Company Details
11.3.2 Company Business Overview
11.3.3 Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Products Offered
11.3.5 Bausch & Lomb Incorporated Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Company Business Overview
11.4.3 Novartis AG Ophthalmic Therapeutics/Drug Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Novartis AG Ophthalmic Therapeutics/Drug Products Offered
11.4.5 Novartis AG Recent Development
11.5 Merck Sharp & Dohme Corp.
11.5.1 Merck Sharp & Dohme Corp. Company Details
11.5.2 Company Business Overview
11.5.3 Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Products Offered
11.5.5 Merck Sharp & Dohme Corp. Recent Development
11.6 Regeneron Pharmaceuticals Inc.
11.6.1 Regeneron Pharmaceuticals Inc. Company Details
11.6.2 Company Business Overview
11.6.3 Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Products Offered
11.6.5 Regeneron Pharmaceuticals Inc. Recent Development
11.7 Allergan
11.7.1 Allergan Company Details
11.7.2 Company Business Overview
11.7.3 Allergan Ophthalmic Therapeutics/Drug Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Allergan Ophthalmic Therapeutics/Drug Products Offered
11.7.5 Allergan Recent Development
11.8 Pfizer Inc.
11.8.1 Pfizer Inc. Company Details
11.8.2 Company Business Overview
11.8.3 Pfizer Inc. Ophthalmic Therapeutics/Drug Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Pfizer Inc. Ophthalmic Therapeutics/Drug Products Offered
11.8.5 Pfizer Inc. Recent Development
11.9 Valeant
11.9.1 Valeant Company Details
11.9.2 Company Business Overview
11.9.3 Valeant Ophthalmic Therapeutics/Drug Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Valeant Ophthalmic Therapeutics/Drug Products Offered
11.9.5 Valeant Recent Development
11.10 Bayer AG
11.10.1 Bayer AG Company Details
11.10.2 Company Business Overview
11.10.3 Bayer AG Ophthalmic Therapeutics/Drug Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Bayer AG Ophthalmic Therapeutics/Drug Products Offered
11.10.5 Bayer AG Recent Development
11.11 Santen Pharmaceuticals Co. Ltd
11.12 Genentech, Inc.

12 Future Forecast
12.1 Ophthalmic Therapeutics/Drug Market Forecast by Regions
12.1.1 Global Ophthalmic Therapeutics/Drug Sales Forecast by Regions 2019-2025
12.1.2 Global Ophthalmic Therapeutics/Drug Revenue Forecast by Regions 2019-2025
12.2 Ophthalmic Therapeutics/Drug Market Forecast by Product
12.2.1 Global Ophthalmic Therapeutics/Drug Sales Forecast by Product 2019-2025
12.2.2 Global Ophthalmic Therapeutics/Drug Revenue Forecast by Product 2019-2025
12.3 Ophthalmic Therapeutics/Drug Market Forecast by End User
12.4 North America Ophthalmic Therapeutics/Drug Forecast
12.5 Europe Ophthalmic Therapeutics/Drug Forecast
12.6 Asia Pacific Ophthalmic Therapeutics/Drug Forecast
12.7 Central & South America Ophthalmic Therapeutics/Drug Forecast
12.8 Middle East and Africa Ophthalmic Therapeutics/Drug Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Ophthalmic Therapeutics/Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Table

List of Tables and Figures

Figure Ophthalmic Therapeutics/Drug Product Picture
Table Ophthalmic Therapeutics/Drug Market Segments
Table Key Manufacturers Ophthalmic Therapeutics/Drug Covered
Table Global Ophthalmic Therapeutics/Drug Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Ophthalmic Therapeutics/Drug Sales Market Share by Product 2014-2025
Figure Anti-allergy Product Picture
Table Major Manufacturers of Anti-allergy
Figure Anti-VEGF Agents Product Picture
Table Major Manufacturers of Anti-VEGF Agents
Figure Anti-inflammatory Product Picture
Table Major Manufacturers of Anti-inflammatory
Figure Anti-glaucoma Product Picture
Table Major Manufacturers of Anti-glaucoma
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Ophthalmic Therapeutics/Drug Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Dry Eye
Figure Allergies
Figure Glaucoma
Figure Infection
Figure Retinal Disorders
Figure Uveitis
Figure Others
Figure Ophthalmic Therapeutics/Drug Report Years Considered
Figure Global Ophthalmic Therapeutics/Drug Market Size 2014-2025 (Million US$)
Figure Global Ophthalmic Therapeutics/Drug Sales 2014-2025 (K Units)
Table Global Ophthalmic Therapeutics/Drug Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Ophthalmic Therapeutics/Drug Sales by Regions 2014-2019 (K Units)
Table Global Ophthalmic Therapeutics/Drug Sales Market Share by Regions 2014-2019
Figure Global Ophthalmic Therapeutics/Drug Sales Market Share by Regions 2014-2019
Figure 2018 Global Ophthalmic Therapeutics/Drug Sales Market Share by Regions
Table Global Ophthalmic Therapeutics/Drug Revenue by Regions 2014-2019 (Million US$)
Table Global Ophthalmic Therapeutics/Drug Revenue Market Share by Regions 2014-2019
Figure Global Ophthalmic Therapeutics/Drug Revenue Market Share by Regions 2014-2019
Figure 2018 Global Ophthalmic Therapeutics/Drug Revenue Market Share by Regions
Table Global Ophthalmic Therapeutics/Drug Sales by Manufacturers (2014-2019) (K Units)
Table Global Ophthalmic Therapeutics/Drug Sales Share by Manufacturers (2014-2019)
Figure Global Ophthalmic Therapeutics/Drug Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Ophthalmic Therapeutics/Drug Revenue by Manufacturers (2014-2019) (Million USD)
Table Ophthalmic Therapeutics/Drug Revenue Share by Manufacturers (2014-2019)
Figure Ophthalmic Therapeutics/Drug Value Share by Manufacturers in 2018
Table Key Manufacturers Ophthalmic Therapeutics/Drug Price (2014-2019) (USD/Unit)
Table Ophthalmic Therapeutics/Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Ophthalmic Therapeutics/Drug Product Type
Table Date of International Manufacturers Enter into Ophthalmic Therapeutics/Drug Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Ophthalmic Therapeutics/Drug Sales by Product (2014-2019) (K Units)
Table Global Ophthalmic Therapeutics/Drug Sales Share by Product (2014-2019)
Figure Global Ophthalmic Therapeutics/Drug Sales Market Share by Product (2014-2019)
Figure Global Ophthalmic Therapeutics/Drug Sales Market Share by Product in 2018
Table Global Ophthalmic Therapeutics/Drug Revenue by Product (2014-2019) (Million US$)
Table Global Ophthalmic Therapeutics/Drug Revenue Share by Product (2014-2019)
Figure Global Ophthalmic Therapeutics/Drug Revenue Market Share by Product (2014-2019)
Figure Global Ophthalmic Therapeutics/Drug Revenue Market Share by Product in 2018
Table Ophthalmic Therapeutics/Drug Price by Product 2014-2019 (USD/Unit)
Table Global Ophthalmic Therapeutics/Drug Sales by End User (2014-2019) (K Units)
Table Global Ophthalmic Therapeutics/Drug Sales Share by End User (2014-2019)
Figure Global Sales Ophthalmic Therapeutics/Drug Market Share by End User (2014-2019)
Figure Global Sales Ophthalmic Therapeutics/Drug Market Share by End User in 2018
Figure North America Ophthalmic Therapeutics/Drug Sales Growth Rate 2014-2019 (K Units)
Figure North America Ophthalmic Therapeutics/Drug Revenue Growth Rate 2014-2019 (Million US$)
Table North America Ophthalmic Therapeutics/Drug Sales by Countries (2014-2019) (K Units)
Table North America Ophthalmic Therapeutics/Drug Sales Market Share by Countries (2014-2019)
Figure 2018 North America Ophthalmic Therapeutics/Drug Sales Market Share by Countries
Table North America Ophthalmic Therapeutics/Drug Revenue by Countries (2014-2019) (Million US$)
Table North America Ophthalmic Therapeutics/Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Ophthalmic Therapeutics/Drug Revenue Market Share by Countries
Figure United States Ophthalmic Therapeutics/Drug Sales Growth Rate (2014-2019) (K Units)
Figure United States Ophthalmic Therapeutics/Drug Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Ophthalmic Therapeutics/Drug Sales Growth Rate (2014-2019) (K Units)
Figure Canada Ophthalmic Therapeutics/Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Ophthalmic Therapeutics/Drug Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Ophthalmic Therapeutics/Drug Revenue Growth Rate (2014-2019) (Million US$)
Table North America Ophthalmic Therapeutics/Drug Sales by Product (2014-2019) (K Units)
Table North America Ophthalmic Therapeutics/Drug Sales Market Share by Product (2014-2019)
Figure 2018 North America Ophthalmic Therapeutics/Drug Market Share by Product
Table North America Ophthalmic Therapeutics/Drug Sales by End User (2014-2019) (K Units)
Table North America Ophthalmic Therapeutics/Drug Sales Market Share by End User (2014-2019)
Figure 2018 North America Ophthalmic Therapeutics/Drug Market Share by End User
Figure Europe Ophthalmic Therapeutics/Drug Sales Growth Rate 2014-2019 (K Units)
Figure Europe Ophthalmic Therapeutics/Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Ophthalmic Therapeutics/Drug Sales by Countries (2014-2019) (K Units)
Table Europe Ophthalmic Therapeutics/Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Ophthalmic Therapeutics/Drug Sales Market Share by Countries
Table Europe Ophthalmic Therapeutics/Drug Revenue by Countries (2014-2019) (Million US$)
Table Europe Ophthalmic Therapeutics/Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Ophthalmic Therapeutics/Drug Revenue Market Share by Countries
Figure Germany Ophthalmic Therapeutics/Drug Sales Growth Rate (2014-2019) (K Units)
Figure Germany Ophthalmic Therapeutics/Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure France Ophthalmic Therapeutics/Drug Sales Growth Rate (2014-2019) (K Units)
Figure France Ophthalmic Therapeutics/Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Ophthalmic Therapeutics/Drug Sales Growth Rate (2014-2019) (K Units)
Figure UK Ophthalmic Therapeutics/Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Ophthalmic Therapeutics/Drug Sales Growth Rate (2014-2019) (K Units)
Figure Italy Ophthalmic Therapeutics/Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Ophthalmic Therapeutics/Drug Sales Growth Rate (2014-2019) (K Units)
Figure Russia Ophthalmic Therapeutics/Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Ophthalmic Therapeutics/Drug Sales by Product (2014-2019) (K Units)
Table Europe Ophthalmic Therapeutics/Drug Sales Market Share by Product (2014-2019)
Figure 2018 Europe Ophthalmic Therapeutics/Drug Market Share by Product
Table Europe Ophthalmic Therapeutics/Drug Sales by End User (2014-2019) (K Units)
Table Europe Ophthalmic Therapeutics/Drug Sales Market Share by End User (2014-2019)
Figure 2018 Europe Ophthalmic Therapeutics/Drug Market Share by End User
Figure Asia Pacific Ophthalmic Therapeutics/Drug Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Ophthalmic Therapeutics/Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Ophthalmic Therapeutics/Drug Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Ophthalmic Therapeutics/Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Ophthalmic Therapeutics/Drug Sales Market Share by Countries
Table Asia Pacific Ophthalmic Therapeutics/Drug Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Ophthalmic Therapeutics/Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Ophthalmic Therapeutics/Drug Revenue Market Share by Countries
Figure China Ophthalmic Therapeutics/Drug Sales Growth Rate (2014-2019) (K Units)
Figure China Ophthalmic Therapeutics/Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Ophthalmic Therapeutics/Drug Sales Growth Rate (2014-2019) (K Units)
Figure Japan Ophthalmic Therapeutics/Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Ophthalmic Therapeutics/Drug Sales Growth Rate (2014-2019) (K Units)
Figure Korea Ophthalmic Therapeutics/Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure India Ophthalmic Therapeutics/Drug Sales Growth Rate (2014-2019) (K Units)
Figure India Ophthalmic Therapeutics/Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Ophthalmic Therapeutics/Drug Sales Growth Rate (2014-2019) (K Units)
Figure Australia Ophthalmic Therapeutics/Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Ophthalmic Therapeutics/Drug Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Ophthalmic Therapeutics/Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Ophthalmic Therapeutics/Drug Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Ophthalmic Therapeutics/Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Ophthalmic Therapeutics/Drug Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Ophthalmic Therapeutics/Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Ophthalmic Therapeutics/Drug Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Ophthalmic Therapeutics/Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Ophthalmic Therapeutics/Drug Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Ophthalmic Therapeutics/Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Ophthalmic Therapeutics/Drug Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Ophthalmic Therapeutics/Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Ophthalmic Therapeutics/Drug Sales by Product (2014-2019) (K Units)
Table Asia Pacific Ophthalmic Therapeutics/Drug Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Ophthalmic Therapeutics/Drug Market Share by Product
Table Asia Pacific Ophthalmic Therapeutics/Drug Sales by End User (2014-2019) (K Units)
Table Asia Pacific Ophthalmic Therapeutics/Drug Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Ophthalmic Therapeutics/Drug Market Share by End User
Figure Central & South America Ophthalmic Therapeutics/Drug Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Ophthalmic Therapeutics/Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Ophthalmic Therapeutics/Drug Sales by Countries (2014-2019) (K Units)
Table Central & South America Ophthalmic Therapeutics/Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Ophthalmic Therapeutics/Drug Sales Market Share by Countries
Table Central & South America Ophthalmic Therapeutics/Drug Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Ophthalmic Therapeutics/Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Ophthalmic Therapeutics/Drug Revenue Market Share by Countries
Figure Brazil Ophthalmic Therapeutics/Drug Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Ophthalmic Therapeutics/Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Ophthalmic Therapeutics/Drug Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Ophthalmic Therapeutics/Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Ophthalmic Therapeutics/Drug Sales by Product (2014-2019) (K Units)
Table Central & South America Ophthalmic Therapeutics/Drug Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Ophthalmic Therapeutics/Drug Market Share by Product
Table Central & South America Ophthalmic Therapeutics/Drug Sales by End User (2014-2019) (K Units)
Table Central & South America Ophthalmic Therapeutics/Drug Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Ophthalmic Therapeutics/Drug Market Share by End User
Figure Middle East and Africa Ophthalmic Therapeutics/Drug Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Ophthalmic Therapeutics/Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Ophthalmic Therapeutics/Drug Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Ophthalmic Therapeutics/Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Ophthalmic Therapeutics/Drug Sales Market Share by Countries
Table Middle East and Africa Ophthalmic Therapeutics/Drug Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Ophthalmic Therapeutics/Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Ophthalmic Therapeutics/Drug Revenue Market Share by Countries
Figure GCC Countries Ophthalmic Therapeutics/Drug Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Ophthalmic Therapeutics/Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Ophthalmic Therapeutics/Drug Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Ophthalmic Therapeutics/Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Ophthalmic Therapeutics/Drug Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Ophthalmic Therapeutics/Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Ophthalmic Therapeutics/Drug Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Ophthalmic Therapeutics/Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Ophthalmic Therapeutics/Drug Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Ophthalmic Therapeutics/Drug Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Ophthalmic Therapeutics/Drug Market Share by Product
Table Middle East and Africa Ophthalmic Therapeutics/Drug Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Ophthalmic Therapeutics/Drug Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Ophthalmic Therapeutics/Drug Market Share by End User
Table Alcon Company Details
Table Alcon Ophthalmic Therapeutics/Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Alcon Recent Development

Table Johnson and Johnson Vision Care, Inc. Company Details
Table Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson and Johnson Vision Care, Inc. Recent Development

Table Bausch & Lomb Incorporated Company Details
Table Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bausch & Lomb Incorporated Recent Development

Table Novartis AG Company Details
Table Novartis AG Ophthalmic Therapeutics/Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis AG Recent Development

Table Merck Sharp & Dohme Corp. Company Details
Table Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Sharp & Dohme Corp. Recent Development

Table Regeneron Pharmaceuticals Inc. Company Details
Table Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Regeneron Pharmaceuticals Inc. Recent Development

Table Allergan Company Details
Table Allergan Ophthalmic Therapeutics/Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Allergan Recent Development

Table Pfizer Inc. Company Details
Table Pfizer Inc. Ophthalmic Therapeutics/Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Inc. Recent Development

Table Valeant Company Details
Table Valeant Ophthalmic Therapeutics/Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Valeant Recent Development

Table Bayer AG Company Details
Table Bayer AG Ophthalmic Therapeutics/Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer AG Recent Development

Table Santen Pharmaceuticals Co. Ltd Company Details
Table Genentech, Inc. Company Details
Table Global Ophthalmic Therapeutics/Drug Sales Forecast by Regions 2019-2025 (K Units)
Table Global Ophthalmic Therapeutics/Drug Sales Market Share Forecast by Regions 2019-2025
Table Global Ophthalmic Therapeutics/Drug Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Ophthalmic Therapeutics/Drug Revenue Market Share Forecast by Regions 2019-2025
Table Global Ophthalmic Therapeutics/Drug Sales Forecast by Product 2019-2025 (K Units)
Table Global Ophthalmic Therapeutics/Drug Sales Market Share Forecast by Product 2019-2025
Table Global Ophthalmic Therapeutics/Drug Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Ophthalmic Therapeutics/Drug Revenue Market Share Forecast by Product 2019-2025
Table Global Ophthalmic Therapeutics/Drug Sales Forecast by End User 2019-2025 (K Units)
Table Global Ophthalmic Therapeutics/Drug Sales Market Share Forecast by End User 2019-2025
Figure North America Ophthalmic Therapeutics/Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Ophthalmic Therapeutics/Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Ophthalmic Therapeutics/Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Ophthalmic Therapeutics/Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Ophthalmic Therapeutics/Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Ophthalmic Therapeutics/Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Ophthalmic Therapeutics/Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Ophthalmic Therapeutics/Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Ophthalmic Therapeutics/Drug Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Ophthalmic Therapeutics/Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Ophthalmic Therapeutics/Drug Value Chain
Table Ophthalmic Therapeutics/Drug Customers List
Table Ophthalmic Therapeutics/Drug Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *